MDS & MPN
Day 2: Friday, 17th February, 2017
|
Session Chief: |
Maj Gen Parvez Ahmed |
|
Chair Person: |
Prof. Dr. Zeba Aziz |
|
Moderator: |
Dr. Neelam Mazhar |
|
SESSION VI: 09:00am - 11:55pm |
||
|
Time |
Speakers |
Topic |
|
09:00am – 09:20am |
Prof. Dr. Samina Naeem |
Updates of Diagnosis of Myeloproliferative Neoplasms |
|
09:20am – 09:40am |
Prof. Dr. Timothy P Hughes |
Chronic Myeloid Leukemia |
|
09:40am – 10:00am |
Maj. Gen. Saleem Ahmed Khan |
MDS 2016 update on WHO Classification |
|
10:00am – 10:20am |
Maj. Gen. Naeem Naqi |
Philadelphia Negative MPN |
|
10:20am – 10:40am |
Col. Muhammad Naeem |
Role of Flowcytometry in Diagnosis of MDS |
|
FREE PAPER |
||
|
Time |
Presenter |
Topic |
|
10:40am – 10:50am |
Dr. Nida Anwar |
Clinicohematological and Cytogenetic Profile of Myelodysplastic Syndromes in Pakistan-Compare and Contrast |
|
10:50am – 11:00am |
Dr. Neelam Mazhar |
Frequency of myelodysplastic syndrome and Clinicohaematological features in Paediatric Population |
|
11:00am – 11:15am |
Tea Break |
|
|
11:15am – 11:25am |
Dr. Uzma Zaidi |
Disease spectrum and clinical outcome of phildelphia negative myeloprolifrative neoplasm in Pakistani population |
|
11:25am – 11:35am |
Dr. Syed Zubair Shah |
Somatic JAK-2V617F mutational analysis in BCRABL negative MPN: a Tertiary Care Center experience |
|
11:35am – 11:45am |
Dr. Rafia Mahmood |
Myelodysplastic syndrome clinicohaematological characteristics, cytogenetic profile and risk stratification |
|
11:45am – 11:55am |
Dr. Faiqa Aslam |
Quantitative estimation of BCR-ABL1 Fusion Gene RNA in Patients of Chronic Myeloid Leukemia (CML) Undergoing Treatment with tyrosine kinase inhibitors |
